Insufficient scRNA-seq data for expression of DNASE2B at single-cell level.
Insufficient scRNA-seq data for expression of DNASE2B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 89% | 111.92 | 218 / 245 | 99% | 32.69 | 496 / 502 |
| lung | 87% | 108.40 | 505 / 578 | 31% | 0.87 | 353 / 1155 |
| brain | 82% | 19.90 | 2157 / 2642 | 32% | 0.77 | 226 / 705 |
| muscle | 90% | 54.01 | 722 / 803 | 0% | 0 | 0 / 0 |
| breast | 53% | 16.79 | 241 / 459 | 28% | 1.75 | 317 / 1118 |
| stomach | 69% | 28.24 | 247 / 359 | 12% | 0.29 | 33 / 286 |
| spleen | 77% | 21.63 | 185 / 241 | 0% | 0 | 0 / 0 |
| thymus | 53% | 6.16 | 343 / 653 | 21% | 0.39 | 129 / 605 |
| skin | 12% | 1.34 | 218 / 1809 | 60% | 15.66 | 281 / 472 |
| adrenal gland | 54% | 6.01 | 139 / 258 | 9% | 0.16 | 20 / 230 |
| intestine | 43% | 9.55 | 416 / 966 | 13% | 0.26 | 69 / 527 |
| pancreas | 25% | 3.48 | 81 / 328 | 31% | 4.09 | 55 / 178 |
| adipose | 51% | 23.27 | 612 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 15% | 1.28 | 13 / 89 | 29% | 1.02 | 257 / 901 |
| lymph node | 0% | 0 | 0 / 0 | 34% | 1.29 | 10 / 29 |
| bladder | 19% | 1.81 | 4 / 21 | 10% | 0.24 | 49 / 504 |
| blood vessel | 28% | 8.09 | 372 / 1335 | 0% | 0 | 0 / 0 |
| liver | 9% | 0.88 | 20 / 226 | 10% | 0.19 | 41 / 406 |
| esophagus | 5% | 0.40 | 73 / 1445 | 10% | 0.26 | 18 / 183 |
| heart | 12% | 1.02 | 100 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 0.61 | 5 / 45 |
| uterus | 5% | 0.42 | 8 / 170 | 3% | 0.07 | 15 / 459 |
| eye | 0% | 0 | 0 / 0 | 8% | 0.17 | 6 / 80 |
| ovary | 6% | 1.09 | 11 / 180 | 1% | 0.03 | 5 / 430 |
| peripheral blood | 2% | 0.40 | 15 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006309 | Biological process | apoptotic DNA fragmentation |
| GO_0005764 | Cellular component | lysosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0004531 | Molecular function | deoxyribonuclease II activity |
| Gene name | DNASE2B |
| Protein name | Deoxyribonuclease-2-beta (EC 3.1.22.1) (DNase II-like acid DNase) (DNase2-like acid DNase) (Deoxyribonuclease II beta) (DNase II beta) (Endonuclease DLAD) Deoxyribonuclease-2-beta (EC 3.1.22.1) (DNase II-like acid DNase) (DNase2-like acid DNase) (Deoxyribonuclease II beta) (Endonuclease DLAD) |
| Synonyms | DLAD |
| Description | FUNCTION: Hydrolyzes DNA under acidic conditions. Does not require divalent cations for activity. Participates in the degradation of nuclear DNA during lens cell differentiation. . FUNCTION: Hydrolyzes DNA under acidic conditions. Does not require divalent cations for activity. Participates in the degradation of nuclear DNA during lens cell differentiation. . FUNCTION: Hydrolyzes DNA under acidic conditions. Does not require divalent cations for activity. Participates in the degradation of nuclear DNA during lens cell differentiation. . |
| Accessions | Q66K39 Q8WZ79 A0AUY7 ENST00000370662.3 [Q8WZ79-2] ENST00000370665.4 [Q8WZ79-1] |